BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38508372)

  • 1. Insights into the trypanothione system in antimony-resistant and sensitive Leishmania tropica clinical isolates.
    Valashani HT; Ahmadpour M; Naddaf SR; Mohebali M; Hajjaran H; Latifi A; Salimi M; Farahmand M; Naeimi S; Raissi V; Kazemirad E
    Acta Trop; 2024 Jun; 254():107190. PubMed ID: 38508372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.
    Mohebali M; Kazemirad E; Hajjaran H; Kazemirad E; Oshaghi MA; Raoofian R; Teimouri A
    Arch Dermatol Res; 2019 Jan; 311(1):9-17. PubMed ID: 30390113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
    Nateghi-Rostami M; Tasbihi M; Darzi F
    Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
    Hajjaran H; Kazemi-Rad E; Mohebali M; Oshaghi MA; Khadem-Erfan MB; Hajaliloo E; Reisi Nafchi H; Raoofian R
    Int J Dermatol; 2016 Sep; 55(9):1020-6. PubMed ID: 27336481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
    Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
    Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ubiquitin and amino acid permease genes in association with antimony resistance in Leishmania tropica field isolates.
    Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Saffari M; Raoofian R; Heidari M
    Korean J Parasitol; 2013 Aug; 51(4):413-9. PubMed ID: 24039283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
    Oliaee RT; Sharifi I; Afgar A; Kareshk AT; Asadi A; Heshmatkhah A; Bamorovat M; Jafarzadeh A; Mohammadi MA; Daneshvar H
    Trop Med Int Health; 2018 Jun; 23(6):622-633. PubMed ID: 29709098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of Antimony Resistance Mechanism of Leishmania tropica Causing Cutaneous Leishmaniasis in Turkey].
    Özbilgin A; Zeyrek FY; Güray MZ; Çulha G; Akyar I; Harman M; Özbel Y; Ertabaklar H; Çavuş İ; Gündüz C
    Mikrobiyol Bul; 2020 Jul; 54(3):444-462. PubMed ID: 32755520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.
    Khanra S; Das S; Sarraf NR; Datta S; Das AK; Manna M; Roy S
    Front Cell Infect Microbiol; 2022; 12():1021464. PubMed ID: 36405965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
    Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
    Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
    Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
    PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
    Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
    Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
    J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.
    Barrera MC; Rojas LJ; Weiss A; Fernandez O; McMahon-Pratt D; Saravia NG; Gomez MA
    Acta Trop; 2017 Dec; 176():355-363. PubMed ID: 28843396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
    Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infecting glial cells with antimony resistant Leishmania tropica: A new ex-vivo model].
    Zorbozan O; Harman M; Evren V; Erdoğan MA; Kılavuz A; Tunalı V; Çavuş İ; Yılmaz Ö; Özbilgin A; Turgay N
    Mikrobiyol Bul; 2018 Jan; 52(1):49-55. PubMed ID: 29642829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.
    Jeddi F; Mary C; Aoun K; Harrat Z; Bouratbine A; Faraut F; Benikhlef R; Pomares C; Pratlong F; Marty P; Piarroux R
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4866-74. PubMed ID: 24913173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.